Chad J. Wasserman serves as Executive at HCA Healthcare, Inc., where they oversee executive responsibilities. Since joining the company, Chad J. Wasserman has executed 9 insider transactions totaling $603.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 20, 2024 involved selling 876 shares valued at $289.3K.
Chad J. Wasserman currently holds 1,576.31 shares of HCA Healthcare, Inc. (HCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chad J. Wasserman has been a net seller of HCA stock. They have purchased $0 and sold $603.5K worth of shares.
Chad J. Wasserman's most recent insider trade was on Mar 20, 2024, when they sold 876 shares at $330.25 per share.
Get notified when new Form 4 filings are submitted
| $321.97 |
| Planned |
| Mar 18, 2024 | HCA | $400.5K | Payment | 1,224 | $327.17 | Planned |
| Mar 18, 2024 | HCA | $212.4K | Option Exercise | 2,100 | $101.16 | Planned |
| Feb 16, 2024 | HCA | $154.0K | Payment | 499 | $308.55 | Discretionary |
| Feb 16, 2024 | HCA | $0 | Award | 2,040 | $N/A | Discretionary |
| Feb 3, 2024 | HCA | $0 | Option Exercise | 127 | $N/A | Discretionary |
| Feb 3, 2024 | HCA | $11.8K | Payment | 38 | $309.42 | Discretionary |
| Feb 2, 2024 | HCA | $203.5K | Sale | 652 | $312.04 | Discretionary |